Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Biologic treatments for systemic rheumatic diseases Shirota Y; Illei GG; Nikolov NPOral Dis 2008[Apr]; 14 (3): 206-16Many rheumatologic disorders, most notably Sjogren's syndrome, are associated with dental complications and in some cases oral diseases may trigger or drive connective tissue disease. During the past three decades the treatment in rheumatology was revolutionized by the introduction of disease-modifying anti-rheumatic drugs. Advances in our understanding of the pathogenesis of rheumatic diseases have led to the discovery of critical mechanisms of inflammation and autoimmunity and the invention of new target-specific biologic agents. In this review, we will summarize the current state of biologic therapies in rheumatology and discuss the implications of these on oral health and disease.|Abatacept[MESH]|Animals[MESH]|Antibodies, Monoclonal/immunology/*therapeutic use[MESH]|Antirheumatic Agents/*therapeutic use[MESH]|B-Cell Activating Factor/immunology[MESH]|Humans[MESH]|Immunoconjugates/immunology[MESH]|Immunologic Factors/*therapeutic use[MESH]|Interferon-alpha/immunology[MESH]|Interleukins/immunology[MESH]|Lymphocyte Activation[MESH]|Rheumatic Diseases/drug therapy/immunology/*therapy[MESH]|Sialic Acid Binding Ig-like Lectin 2/immunology[MESH]|Sjogren's Syndrome/drug therapy/*therapy[MESH]|Tumor Necrosis Factor-alpha/immunology[MESH] |
